×
About 36,058 results

ALLMedicine™ Escherichia Coli Center

Research & Reviews  12,992 results

The deletion of yeaJ gene facilitates Escherichia coli escape from immune recognition.
https://doi.org/10.1128/JB.00336-21
Journal of Bacteriology; Wang X, Lin X et. al.

Jul 26th, 2021 - Mammary gland-derived Escherichia coli (E. coli) is an important pathogen causing dairy cow mastitis. Mammary gland mucosal immunity against infectious E. coli mainly depends on recognition of pathogen-associated molecular patterns by innate recep...

Modulation of the enzymatic activity of the flagellar lytic transglycosylase SltF by ro...
https://doi.org/10.1128/JB.00372-21
Journal of Bacteriology; García-Ramos M, de la Mora J et. al.

Jul 26th, 2021 - Macromolecular cell-envelope-spanning structures such as the bacterial flagellum must traverse the cell wall. Lytic transglycosylases enzymes are capable of enlarging gaps in the peptidoglycan meshwork to allow the efficient assembly of supramolec...

Activation by TyrR in Escherichia coli K-12 by Interaction between TyrR and the α-subun...
https://doi.org/10.1128/JB.00252-21
Journal of Bacteriology; Camakaris H, Yang J et. al.

Jul 26th, 2021 - A novel selection was developed for RpoA α-CTD mutants altered in activation by the TyrR regulatory protein of E. coli K-12. This allowed the identification of an aspartate to asparagine substitution in residue 250 (DN250) as an Act- mutation. Ami...

Genome characterization of ESBL-producing multidrug-resistant Escherichia coli in Rabat...
https://doi.org/10.1016/j.jgar.2021.07.008
Journal of Global Antimicrobial Resistance; Ambroise J, Benaissa E et. al.

Jul 25th, 2021 - Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli are an increasingly significant cause of hospital and community-acquired infections worldwide. Whereas several reports have highlighted their increased prevalence also in North Afr...

see more →

Guidelines  4 results

Consumption of raw or unpasteurized milk and milk products by pregnant women and children.
https://doi.org/10.1542/peds.2013-3502
Pediatrics , et. al.

Dec 17th, 2013 - Sales of raw or unpasteurized milk and milk products are still legal in at least 30 states in the United States. Raw milk and milk products from cows, goats, and sheep continue to be a source of bacterial infections attributable to a number of vir...

Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteria...
https://doi.org/10.1016/j.ijantimicag.2010.05.014
International Journal of Antimicrobial Agents; Cohen Stuart J, Leverstein-Van Hall MA et. al.

Jul 5th, 2010 - Adequate detection of carbapenemase-producing Enterobacteriaceae is crucial for infection control measures and appropriate choice of antimicrobial therapy. This guideline aims to improve the detection of carbapenemase-producing Enterobacteriaceae ...

Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by ...
https://www.ncbi.nlm.nih.gov/pubmed/19834454
MMWR. Recommendations and Reports : Morbidity and Mortali... Gould LH, Bopp C et. al.

Oct 16th, 2009 - Shiga toxin--producing Escherichia coli (STEC) are a leading cause of bacterial enteric infections in the United States. Prompt, accurate diagnosis of STEC infection is important because appropriate treatment early in the course of infection might...

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic urem...
https://doi.org/10.1007/s00467-008-0964-1
Pediatric Nephrology (Berlin, Germany); Ariceta G, Besbas N et. al.

Sep 18th, 2008 - This guideline for the investigation and initial treatment of atypical hemolytic uremic syndrome (HUS) is intended to offer an approach based on opinion, as evidence is lacking. It builds on the current ability to identify the etiology of specific...

see more →

Drugs  1,078 results see all →

Clinicaltrials.gov  60 results

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)
https://clinicaltrials.gov/ct2/show/NCT03365921

May 3rd, 2020 - This study is a mono-center, randomization, double-blind clinical trial in healthy subjects between 18 to 50. Under the premise of full informed consent, 360 subjects that meet the requirement of clinical trial in the age of 18-50 will be divided ...

Phase 1 Study of dmLT ID Vaccination in Healthy Adults
https://clinicaltrials.gov/ct2/show/NCT02531685

Apr 30th, 2020 - This is a randomized, double-blinded, single site outpatient Phase 1 study in healthy adults to determine the safety and immunogenicity of an Enterotoxigenic Escherichia coli (ETEC) candidate vaccine, attenuated recombinant Double Mutant Heat-Labi...

SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance
https://clinicaltrials.gov/ct2/show/NCT03313128

Apr 8th, 2020 - This is a controlled cohort study to assess the effect of improved sanitation on oral rotavirus vaccine performance in low-income urban neighbourhoods of Maputo, Mozambique. The specific hypotheses are that: (1) access to improved sanitation is as...

The Effect of Riboflavin in Crohn's Disease
https://clinicaltrials.gov/ct2/show/NCT02538354

Apr 2nd, 2020 - Rationale Recent studies show that in patients with Inflammatory Bowel Disease (IBD) a dysbiosis exists in the composition of the intestinal microbiota. In particular, the potentially pathogenic bacterium Escherichia coli (E. coli) is often more a...

Special Drug Use Investigation of Ciproxan Injection in Pediatrics
https://clinicaltrials.gov/ct2/show/NCT02555059

Feb 27th, 2020 - This company-sponsored study is an one-arm, prospective, and, cohort-observational study in pediatrics (less than 15 years old) administered Ciproxan injection. All patients in the contracted institute should be enrolled into this study. Consequen...

see more →

News  284 results

FDA Approves New Asparaginase Product for Leukemia
https://www.medscape.com/viewarticle/954149

Jul 1st, 2021 - The US Food and Drug Administration (FDA) has approved a new version of asparaginase for use in children and adults who have developed hypersensitivity to asparaginase derived from Escherichia coli. The new product is Jazz Pharmaceutical's Rylaze ...

Adherent-Invasive E. Coli Metabolism Drives Inflammation in Crohn's Disease
https://www.medscape.com/viewarticle/945997

Feb 17th, 2021 - NEW YORK (Reuters Health) - Researchers have identified the process by which adherent-invasive Escherichia coli (AIEC) bacteria drive inflammation in Crohn's disease. They found that AIEC, which colonize the intestinal mucosa by adhering to and in...

What I Didn't Know About Urine Blew My Mind
https://www.staging.medscape.com/viewarticle/938016

Oct 4th, 2020 - This transcript has been edited for clarity. Matthew F. Watto, MD: Welcome back to the Curbsiders. I'm Dr Matthew Frank Watto, here with my glorious friend Dr Paul Nelson Williams. So, Paul, what are we doing on today's video? Paul N. Williams, MD...

Fecal Microbiota for Transplantation: Safety Alert - Risk of Serious Adverse Events Likely Due to Transmission of Pathogenic Organisms | FDA
https://www.fda.gov/safety/medical-product-safety-information/fecal-microbiota-transplantation-safety-alert-risk-serious-adverse-events-likely-due-transmission

[Update Posted 04/07/2020] [Posted 03/12/2020] AUDIENCE: Patient, Health Professional ISSUE: FDA is informing health care providers and patients of the potential risk of serious or life-threatening infections with the use of fecal microbiota for t...

Heritage Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) as a Result o...
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/heritage-pharmaceuticals-inc-issues-voluntary-nationwide-recall-amikacin-sulfate-injection-usp-1gm4

Summary Company Announcement Date: May 28, 2019 FDA Publish Date: May 28, 2019 Product Type: Drugs Reason for Announcement: Recall Reason Description Sterility Failure Company Name: Heritage Pharmaceuticals Inc. Brand Name: Brand Name(s) Heritage ...

see more →

Patient Education  5 results see all →